Influenza Diagnostics Market to Reach USD 2.41 Billion by 2030; Driven by growing Adoption of Point-of-care (POC) Testing

Mordor Intelligence has published a new report on influenza diagnostics market offering a comprehensive analysis of trends, growth drivers, and future projections.
Introduction

The influenza diagnostics market [https://www.mordorintelligence.com/industry-reports/influenza-diagnostics-market?utm_source=abnewswire] encompassing test kits, reagents, and diagnostic assays for detecting influenza viruses is poised for steady growth in the coming years. According to a comprehensive market analysis by industry researcher Mordor Intelligence, The influenza diagnostics market size stood at USD 1.82 billion in 2025 and is forecast to reach USD 2.41 billion by 2030, advancing at a 5.8% CAGR through the period.

This growth reflects a return to more routine, non-emergency use of flu diagnostics, supported by increasing demand for accurate molecular tests, growing adoption of point-of-care (POC) testing, and heightened investments in surveillance infrastructure around the world.

Key Market Trends

Rising Demand for Molecular Diagnostics in Influenza Testing

One of the major trends shaping the influenza diagnostics market is the shift from traditional rapid antigen tests toward molecular diagnostic platforms. Molecular methods, including RT-PCR, isothermal amplification, and novel CRISPR-based assays, offer higher sensitivity and specificity compared to legacy rapid influenza diagnostic tests (RIDTs).

Surge in Point-of-Care and Home-Based Testing

Another key trend is the growing adoption of POC testing and home-based testing solutions. As outpatient clinics, urgent-care centers, and retail pharmacies seek faster diagnosis; point-of-care influenza tests have gained prominence. These tests can deliver results rapidly often within minutes, enabling timely antiviral treatment and reducing patient stay times.

Government Surveillance and Funding Support

Public health priorities and renewed investment in influenza surveillance also drive demand. Many countries are strengthening their laboratory infrastructure and expanding surveillance capacity, as part of ongoing readiness efforts for seasonal and zoonotic influenza outbreaks.

Integration of Digital Tools and Workflow Automation

Advances in digital health including AI-enabled result-interpretation software are helping laboratories increase throughput, reduce turnaround times, and improve quality control. Such tools streamline molecular diagnostic workflows and enable labs to process more tests during influenza peaks without necessarily expanding physical infrastructure.

Market Segmentation

By Test Type

*
Traditional Diagnostic Tests

*
Rapid Influenza Diagnostic Tests (RIDTs)

*
Direct Fluorescent Antibody (DFA) Tests

*
Viral Culture

*
Rapid Cell Culture

Molecular Diagnostic Tests

*
Reverse-Transcriptase PCR (RT-PCR)

*
Loop-Mediated Isothermal Amplification (LAMP)

*
Nicking-Enzyme Amplification Reaction (NEAR)

*
CRISPR-based Assays

*
Syndromic Multiplex PCR Panels

By End User

*
Hospitals & Clinical Laboratories

*
Independent Diagnostic Laboratories

*
Point-of-Care Settings

*
Others

By Geography

*
North America

*
Europe

*
Asia-Pacific

*
South America

*
Middle East & Africa

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/industry-reports/influenza-diagnostics-market?utm_source=abnewswire

Key Players

Several major global players lead in the influenza diagnostics market, while smaller and innovative companies carve out niches through focused technologies. According to Mordor Intelligence, prominent companies include Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Abbott Laboratories, and QuidelOrtho Corporation.

*
Becton, Dickinson and Company

*
F. Hoffmann-La Roche Ltd

*
Thermo Fisher Scientific

*
Abbott Laboratories

*
QuidelOrtho Corporation

Conclusion

The forecasted growth of the global influenza diagnostics market reflects a shift in how influenza testing is approached. As healthcare systems move past pandemic-era turbulence, demand is stabilizing but evolving. The transition toward molecular diagnostics, rising adoption of point-of-care and home-based testing, and stronger public-health surveillance are reshaping the space.

With a projected market value of USD 2.41 billion by 2030, the influenza diagnostics market is becoming more nuanced: accuracy, speed, convenience, and access increasingly matter. Stakeholders from hospitals and clinical labs to retail clinics and home-health platforms are rethinking how flu testing fits into broader respiratory disease management.

Industry Related Reports:

Hepatitis Diagnostic Test Market [https://www.mordorintelligence.com/industry-reports/hepatitis-diagnostic-test-market?utm_source=abnewswire]: The Hepatitis Diagnostic Test Market Report is Segmented by Product Type (Reagents & Kits and More), Disease Type (Hepatitis B and More), Technology (Serology Tests and More), Sample Type (Blood and More), Test Setting (Hospital Laboratories and More), and Geography (North America, Europe, Asia-Pacific, and More).

HPV Testing And Pap Test [https://www.mordorintelligence.com/industry-reports/hpv-testing-and-pap-test-market?utm_source=abnewswire]: The HPV Testing and Pap Test Market Report is Segmented by Test Type (HPV Testing, Pap Test), Sample Collection Method (Clinician-Collected Cervical Sample, and More), Product & Service (Instruments & Analyzers, and More), Application (Cervical Cancer Screening, and More), End User (Hospitals & Surgical Clinics, and More), and Geography (North America, Europe, and More).

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com https://www.mordorintelligence.com/

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Mordor Intelligence
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=influenza-diagnostics-market-to-reach-usd-241-billion-by-2030-driven-by-growing-adoption-of-pointofcare-poc-testing]
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: United States
Website: https://www.mordorintelligence.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.